# Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients

> **NCT00852020** · NA · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 60 (actual)

## Conditions studied

- Cachexia
- Chronic Obstructive Pulmonary Disease
- Chronic Heart Failure

## Interventions

- **DIETARY_SUPPLEMENT:** oral nutrition supplement, food for special medical purposes

## Key facts

- **NCT ID:** NCT00852020
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852020, "Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00852020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*